Abstract
RATIONALE: thyroid, adrenal, and neuroendocrine neoplasms have the potential to disseminate to bones. About 3% of patients with well-differentiated thyroid tumors develop secondary bone lesions, while adrenal or neuroendocrine tumors have an incidence of 10% and 13%, respectively. Vertebral metastases are associated with a poor prognosis. Systemic progressive disease, post-operative compl…